Introduction. The importance of noninsulin-dependent diabetes mellitus (typ
e II diabetes) as a leading cause of end-stage renal disease is now widely
recognized. The purpose of this study was to assess life-prognosis and its
predictors in a cohort of patients newly entering dialysis.
Material and methods. Eighty-four consecutive type II diabetes patients (40
% of all patients) starting dialysis between 01/01/95 and 31/12/96 were stu
died retrospectively, focusing on clinical data at inception and life-progn
osis after a mean follow-up of 211 days. Patients were divided into three g
roups, according to onset of renal failure: acute 11% (9/84), chronic 61% (
51/84) and acutely aggravated chronic renal failure 28% (25/84).
Results. Patients (mean age 67 years) had longstanding diabetes (mean durat
ion similar to 15 years), heavy proteinuria (similar to 3g/24h) and diabeti
c retinopathy (67%). The average creatinine clearance (Cockcroft's formula)
was 13 ml/min. Cardiovascular diseases were highly prevalent at the start
of dialysis: history of myocardial infarction (26%), angina (36%) and acute
left ventricular dysfunction (67%). More than 80% of the patients underwen
t the first session dialysis under emergency conditions, a situation in par
t related to late referral to the nephrology division (63% for chronic pati
ents). A great majority of the patients were overhydrated when starting dia
lysis, as evidenced by the average weight loss of 6 kg, during the first mo
nth of dialysis, required to reach dry weight. Nearly 64% of the patients p
resented high blood pressure (> 140/90 mmHg) when starting dialysis despite
antihypertensive therapy (mean: 2.3 drugs). The outcome of this type II di
abetes population was dramatic: 32% (27/84) died after a mean follow-up of
211 days, mostly from cardiovascular diseases. The rate of recovery of rena
l function was low in both the acute and the acutely aggravated renal failu
re group (30% and 24%, respectively). Of note, iatrogenic nephrotoxic agent
s accounted for renal function impairment in nearly 30% of patients.
Conclusion. Our observational study illustrates the high burden of cardiova
scular diseases contrasting with sub-optimal cardiovascular therapeutic int
erventions in type II diabetes patients entering dialysis. Factors aggravat
ing renal failure were mainly iatrogenic, and therefore largely avoidable.
Late referral generally implied a poor clinical condition at the start of d
ialysis.